Download PDF
J Pediatr Infect Dis 2024; 19(06): 360-364
DOI: 10.1055/s-0044-1789607
Case Report

Therapeutic Plasma Exchange for a Critically Ill Late Preterm Infant with Multisystem Inflammatory Syndrome of Children: A Case Report and Review of the Literature

Adviye Cakil Saglik 
1   Department of Neonatology, Istanbul Kanuni Sultan Suleyman Research and Training Hospital, University of Health Sciences, Istanbul, Türkiye
,
Seda Yilmaz Semerci 
1   Department of Neonatology, Istanbul Kanuni Sultan Suleyman Research and Training Hospital, University of Health Sciences, Istanbul, Türkiye
,
Erhan Aygun 
1   Department of Neonatology, Istanbul Kanuni Sultan Suleyman Research and Training Hospital, University of Health Sciences, Istanbul, Türkiye
,
Hakan Gemici 
2   Pediatrics, Pediatric Intensive Care Unit Department, Istanbul Kanuni Sultan Suleyman Research and Training Hospital, University of Health Sciences, Istanbul, Türkiye
,
Neval Topal 
3   Pediatric Emergency Department, Istanbul Kanuni Sultan Suleyman Research and Training Hospital, University of Health Sciences, Istanbul, Türkiye
,
Gokhan Buyukkale 
1   Department of Neonatology, Istanbul Kanuni Sultan Suleyman Research and Training Hospital, University of Health Sciences, Istanbul, Türkiye
› Author Affiliations Funding This research did not receive any grant from the public, commercial, or not-for-profit sector funding agencies.
› Further Information
Also available at
    Permissions and Reprints

Abstract

Multisystem inflammatory syndrome of children (MIS-C) is a clinical picture that entered the medical nomenclature after the coronavirus disease 2019 pandemic. Although it primarily affects older children, there have been a limited number of cases reported during the neonatal period. Herein we present a patient, a late preterm infant, with severe MIS-C-related cerebral sinus venous thrombosis who was successfully treated with therapeutic plasma exchange. Practitioners can consider therapeutic plasma exchange as a safe and effective option for the treatment of critically ill MIS-C cases.

Keywords

COVID-19 - MIS-C - newborn - therapeutic plasma exchange

Ethics Approval

Institutional Review Board approval was received from local Ethics Committee of Türkiye Health Sciences University.


Informed Consent

Informed consent was obtained from the parents prior to participation in the study.


Data Availability

All data of the patient are stored in the data recording system of our hospital.




Publication History

Received: 18 January 2024

Accepted: 06 August 2024

Article published online:
29 August 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Deng CX. The global battle against SARS-CoV-2 and COVID-19. Int J Biol Sci 2020; 16 (10) 1676-1677
    CrossrefPubMedSearch in Google Scholar
  • 2 Centers for Disease Control and Prevention. Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). CDC Health Alert Network; 2020.
    PubMed
  • 3 Melgar M, Lee EH, Miller AD. et al. Council of State and Territorial Epidemiologists/CDC surveillance case definition for multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection - United States. MMWR Recomm Rep 2022; 71 (04) 1-14
    CrossrefPubMedSearch in Google Scholar
  • 4 Centers for Disease Control and Prevention (CDC). CSTE. https://ndc.services.cdc.gov/case-definitions/multisystem-inflammatory-syndrome-in-children-mis-c-2023/
    PubMed
  • 5 More K, Aiyer S, Goti A. et al. Multisystem inflammatory syndrome in neonates (MIS-N) associated with SARS-CoV2 infection: a case series. Eur J Pediatr 2022; 181 (05) 1883-1898
    CrossrefPubMedSearch in Google Scholar
  • 6 Zuccotti G, Calcaterra V, Mannarino S. et al. Six-month multidisciplinary follow-up in multisystem inflammatory syndrome in children: an Italian single-center experience. Front Pediatr 2023; 10: 1080654
    CrossrefPubMedSearch in Google Scholar
  • 7 De Rose DU, Pugnaloni F, Calì M. et al. Multisystem inflammatory syndrome in neonates born to mothers with SARS-CoV-2 infection (MIS-N) and in neonates and infants younger than 6 months with acquired COVID-19 (MIS-C): a systematic review. Viruses 2022; 14 (04) 750
    CrossrefPubMedSearch in Google Scholar
  • 8 Jiang L, Tang K, Levin M. et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis 2020; 20 (11) e276-e288
    CrossrefPubMedSearch in Google Scholar
  • 9 Mascarenhas D, Goyal M, Haribalakrishna A, Nanavati R, Ish P, Kunal S. Multisystem inflammatory syndrome in neonates (MIS-N): a systematic review. Eur J Pediatr 2023; 182 (05) 2283-2298
    CrossrefPubMedSearch in Google Scholar
  • 10 Pawar R, Gavade V, Patil N. et al. Neonatal multisystem inflammatory syndrome (MIS-N) associated with prenatal maternal SARS-CoV-2: a case series. Children (Basel) 2021; 8 (07) 572
    PubMedSearch in Google Scholar
  • 11 Sözeri B, Çağlayan Ş, Atasayan V. et al. The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center. Postgrad Med 2021; 133 (08) 994-1000
    CrossrefPubMedSearch in Google Scholar
  • 12 Porosnicu TM, Sirbu IO, Oancea C. et al. The impact of therapeutic plasma exchange on inflammatory markers and acute phase reactants in patients with severe SARS-CoV-2 infection. Medicina (Kaunas) 2023; 59 (05) 867
    CrossrefPubMedSearch in Google Scholar
  • 13 Ebermeyer T, Hequet O, Berard F. et al. The efficacy of therapeutic plasma exchange in COVID-19 patients on endothelial tightness in vitro is hindered by platelet activation. Front Cardiovasc Med 2023; 10: 1094786
    CrossrefPubMedSearch in Google Scholar
  • 14 Durak C, Guney Sahin E, Can YY, Varol F. Retrospective evaluation of therapeutic plasma exchange treatment in a pediatric intensive care unit: single-center experience. Artif Organs 2023; 47 (09) 1464-1471
    CrossrefPubMedSearch in Google Scholar
  • 15 Al-Hashami S, Khamis F, Al-Yahyay M. et al. Therapeutic plasma exchange: a potential therapeutic modality for critically ill adults with severe acute respiratory syndrome coronavirus 2 infection. J Clin Apher 2022; 37 (06) 563-572
    CrossrefPubMedSearch in Google Scholar
  • 16 Atay G, Hasbal C, Türk M, Erdoğan S, Sözeri B. The role of therapeutic plasma exchange (TPE) in multisystem inflammatory syndrome in children (MIS-C). Children (Basel) 2021; 8 (06) 498
    PubMedSearch in Google Scholar
  • 17 Katlan B, Kesici S, Karacanoğlu D. et al. Early is superior to late plasma exchange for severe multisystem inflammatory syndrome in children. J Clin Apher 2022; 37 (03) 281-291
    CrossrefPubMedSearch in Google Scholar
  • 18 Dakay K, Cooper J, Bloomfield J. et al. Cerebral venous sinus thrombosis in COVID-19 infection: a case series and review of the literature. J Stroke Cerebrovasc Dis 2021; 30 (01) 105434
    CrossrefPubMedSearch in Google Scholar
  • 19 Lindan CE, Mankad K, Ram D. et al; ASPNR PECOBIG Collaborator Group. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Health 2021; 5 (03) 167-177
    CrossrefPubMedSearch in Google Scholar
  • 20 Trapani S, Rubino C, Lasagni D. et al. Thromboembolic complications in children with COVID-19 and MIS-C: a narrative review. Front Pediatr 2022; 10: 944743
    CrossrefPubMedSearch in Google Scholar
  • 21 Whitworth H, Sartain SE, Kumar R. et al. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood 2021; 138 (02) 190-198
    CrossrefPubMedSearch in Google Scholar
  • 22 Davies P, Evans C, Kanthimathinathan HK. et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health 2020; 4 (09) 669-677
    CrossrefPubMedSearch in Google Scholar
  • 23 Aguilera-Alonso D, Murias S, Martínez-de-Azagra Garde A. et al; EPICO-AEP Working Group. Prevalence of thrombotic complications in children with SARS-CoV-2. Arch Dis Child 2021; 106 (11) 1129-1132
    CrossrefPubMedSearch in Google Scholar
  • 24 Di Profio E, Leone A, Vizzuso S. et al. Longitudinal anthropometry and body composition in children with SARS-CoV-2-associated multisystem inflammatory syndrome. J Pediatr Gastroenterol Nutr 2023; 76 (04) 505-511
    CrossrefPubMedSearch in Google Scholar
  • 25 National Institutes of Health (NIH). Treatment considerations for children with MIS-C. Accessed February 29, 2024 at: https://www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-children/hospitalized-children-therapeutic-management-of-mis-c/
    PubMed